{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-027556","form_type":"8-K","ticker":"MIR","cik":"0001809987","company_name":"Mirion Technologies, Inc.","filed_at":"2022-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.243469+00:00","generated_at":"2026-06-22T19:06:51.555104+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Mirion Q3 revenues up 11.5% to $160.9M; net loss widens to $50.4M","bullets":["Q3 revenue $160.9M (+11.5% YoY); adjusted revenue growth 8.7%.","GAAP net loss $50.4M ($0.26/share); adjusted EPS $0.03.","Adjusted EBITDA $30.8M, down slightly from $30.9M YoY; order growth 23%, backlog $726M.","FY2022 guidance: reaffirms organic adjusted revenue growth 4-6%; adj. EBITDA $160-170M, adj. EPS $0.37-0.41.","Medical segment posted >20% organic revenue growth; Industrial faced order timing and FX headwinds."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-027556","json":"https://secwatch.observer/filing/0001628280-22-027556.json","markdown":"https://secwatch.observer/filing/0001628280-22-027556.md","text":"https://secwatch.observer/filing/0001628280-22-027556.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809987/000162828022027556/0001628280-22-027556-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809987/000162828022027556/mir-20221101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T19:06:51.555104+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"68dd2d0ab2fbe462b173a0c888a6700a7aa1e154","claim":"Mirion Technologies, Inc. reported year ending December 31, 2022 results: revenue 4% to 6% organic adjusted revenue growth, EPS adjusted EPS of $0.37 to $0.41. Guidance reaffirmed.","evidence_excerpt":"Mirion is updating its guidance for the year ending December 31, 2022: • Reaffirming organic adjusted revenue growth of 4% - 6% • Adjusted EBITDA of $160 million - $170 million • Adjusted EPS of $0.37 - $0.41","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809987/000162828022027556/0001628280-22-027556-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ending December 31, 2022"},{"label":"Revenue","value":"4% to 6% organic adjusted revenue growth"},{"label":"EPS","value":"adjusted EPS of $0.37 to $0.41"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}